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Abstract 
Background—As right ventricular (RV) remodeling in obesity remains under-investigated, and 
the impact of LV diastolic dysfunction on RV hypertrophy is unknown, we aimed to investigate 
1) if sex specific patterns of RV remodeling exist in obesity and 2) whether or not LV diastolic 
dysfunction in obesity is related to RV hypertrophy.   
Methods & Results—739 subjects (females n=345, males n=394) without identifiable 
cardiovascular risk factors, (BMI 15.3–59.2 kg/m2) underwent cardiovascular magnetic 
resonance (1.5T) to measure RV mass (g), RV end-diastolic volume (mls, RV-EDV), RV 
mass/volume ratio (RVM/VR) and LV diastolic peak filling rate (ml/s).  All subjects were 
normotensive (average 119±11 / 73±8 mmHg), normoglycaemic (4.8±0.5mmol/L) and 
normocholesterolaemic (4.8±0.9mmol/L) at the time of scanning. Across both sexes, there was a 
moderately strong positive correlation between BMI and RV mass (males+0.8g, females+1.0g 
per BMI point increase, both p<0.001). Whereas females exhibited RV cavity dilatation (RV-
EDV +1.0ml per BMI point increase, p<0.001), BMI was not correlated with RV-EDV in men 
(R0.04, p=0.51). Concentric RV remodeling was present in both sexes, with RVM/VR being 
positively correlated to BMI (malesR0.41, femalesR0.51, both p<0.001). Irrespective of sex, LV 
peak filling rate was negatively correlated with both RV mass (males R -0.43, females R -0.44, 
both p<0.001) and RVMV/R (males R-0.37, females R-0.35, both p<0.001). 
Conclusions—A sex difference in RV remodeling exists in obesity. Whereas males exhibit 
concentric RV remodeling, females exhibit a mixed pattern of eccentric and concentric 
remodeling. Regardless of sex, reduced LV diastolic function is associated with concentric RV 
remodeling. 
Key Words: sex, RV hypertrophy, obesity, cardiovascular magnetic resonance imaging, diastole 
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There is now a large body of evidence suggesting that obesity is linked to heart failure and 
elevated cardiovascular mortality.
1
  Research into potential mechanisms behind this has almost 
entirely focused on changes in LV morphology, function and mortality and has largely ignored 
the potential role of RV remodeling.  It has recently been shown that RV function is a prognostic 
marker in chronic heart failure, correlating with symptoms, hospital admission rate and 
mortality, 
2, 3
 and also that  and that RV hypertrophy is an independent predictor of heart failure 
and cardiovascular death. 
4
 Therefore, RV remodeling in response to obesity could contribute to 
the observed obesity-related cardiovascular mortality.  
 
One of the potential reasons for the under-investigation of RV remodeling in obesity lies in the 
fact that accurate 2D echocardiographic assessment of RV size and function is inherently more 
difficult as a result the complexity of the shape of the RV, which, in contrast to the ellipsoidal 
shape of the LV, appears triangular when viewed from the side and crescentic when viewed from 
above. This is further hampered by the increased difficulty of generating adequate acoustic 
windows in obesity. Despite these limitations, the majority of these studies have shown RV 
hypertrophy in obesity. 
5-8
 
 
The few previous studies investigating RV geometry in obesity, have, in the main not excluded 
subjects with obesity-related co-morbidities such as hypertension 
9
 which are known to have 
independent effects on RV mass. 
5
 In contrast to echocardiography, cardiovascular magnetic 
resonance (CMR) imaging is ideally suited to investigate RV geometry in obesity as it is not 
hampered by the need for acoustic windows and can accurately integrate RV size and function 
regardless of its shape or the degree of chest wall fat. 
10
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The reasons for the development of RV hypertrophy in obesity, without co-morbidities such as 
obstructive sleep apnoea or systemic arterial hypertension, have not been explored. In the setting 
of systemic arterial hypertension, RV hypertrophy is commonplace 
11
 and has been attributed to 
LV diastolic dysfunction and associated pulmonary venous hypertension. It is proposed that this 
results in increased RV pressure, and compensatory RV hypertrophy. 
12-14
 Given the fact that it is 
well established that obesity is linked to LV diastolic dysfunction 
8, 15, 16
 we hypothesized that a 
similar mechanism of ventricular interaction occurs in obesity.  
 
Although sex-specific patterns of LV remodeling have been shown in obesity 
17, 18
 whether or not 
sex differences in RV remodeling exist in obesity is currently unknown. However, given the sex 
difference in mortality in obesity 
1
 and the evidence that RV hypertrophy is associated with 
increased mortality, a sex difference in the pattern of RV hypertrophy could contribute to sex 
difference in mortality in obesity. 
 
As a result, the aim of this study was to use CMR to investigate 1) The effects of obesity, 
without comorbidities, on RV geometry and function, 2) to determine whether or not there are 
sex differences in RV adaptation to obesity and 3) to investigate whether or not LV diastolic 
function is related to RV hypertrophy in obesity. 
 
Methods 
739 subjects (females n= 345, BMI range 15.3–59.2 kg/m2) without identifiable cardiovascular 
risk factors, were recruited to studies within the University Oxford Centre for Clinical Magnetic 
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Resonance Research (OCMR). All subjects underwent cardiovascular magnetic resonance to 
measure LV and RV morphology and function. The study was approved by the local research 
ethics committee,
 
and informed written consent was obtained from each patient.  
 
Inclusion Criteria 
All subjects were screened for the presence of identifiable cardiac risk factors and excluded if 
they had a history of cardiovascular disease, hypertension, diabetes, smoki g, use of prescription 
medications , were pregnant or under 18 years of age or had a history of obstructive sleep apnoea 
(obese only, by medical interview). All subjects were normotensive at the time of scanning 
(average of three supine measures over ten minutes <140/90mmHg, DINAMAP-1846-SX, 
Critikon Corp).  
 
Anthropometric data  
Fasting blood tests for glucose and cholesterol were taken on the day of the scanning and 
analysed as previously described.  
19
 In addition to BMI fat mass and waist-to-hip ratio were 
evaluated as secondary measures of adiposity. Bio-electrical impedance was used to determine 
total body fat mass using Bodystat © 1500 analyser. For the calculation of the waist: hip ratio 
(WHR), the averag  of three waist measurements was recorded at a) the level of the umbilicus, 
and b) the level of the greater trochanter of the femur.   
 
Right and Left Ventricular Imaging 
All imaging was cardiac gated with a precordial three lead ECG and acquired during end 
expiration breathold. Steady-state free precession cine sequences were used to acquire 
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localization images followed by optimized left ventricular horizontal and vertical long-axis cines. 
These were used to acquire a steady-state free precession (SSFP) short-axis stack aligned to the 
left ventricle to obtain coverage of the entire left and right ventricles (echo time 1.5ms, a 
repetition time of 3.0ms, temporal resolution 47.84ms, slice thickness 7mm, interslice gap 3mm, 
flip angle of 60
◦
), as previously described. 
20-22
 RV concentric hypertrophy/remodelling was 
defined in this study as an increase in RV mass accompanied by an increase in RV Mass: 
Volume ratio, RV eccentric hypertrophy/remodelling was defined as an   increase in RV mass 
without change or decrease in  RV Mass: Volume ratio. 
 
Data Analysis 
Image analysis for ventricular volumes and mass was performed using cmr42
 
© (Circle 
Cardiovascular Imaging Inc, Calgary, Canada) as previously described. 
18
 Intra-observer 
coefficient of variation for RV mass with this method is excellent (9% RV-EDV, 12% RV mass 
in this study), and in keeping with previously reported data from this group. 
23
  
 
LV Diastolic Function Analysis  
Analysis for LV volumes was performed using CMR
42 
© imaging analysis software. LV short 
axis images were manually contoured from base to apex, and across the cardiac cycle to generate 
volume-time curves. All diastolic peak filling rate measurements (ml/s) were normalized to end-
diastolic volume (EDV/s), as previously described. 
24
 On reproducibility analysis, there was 
good inter-observer (8%) and intra-observer (6%) variability in the peak filling rate 
measurement.   
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Statistical Analysis 
All statistics were analysed using SPSS 20 (Chicago, Ill) and STATA (StataCorp, Texas). All 
data were subjected to Kolmogorov–Smirnov tests to establish normal distribution of the data. 
All presented data was normally distributed and is presented as the mean ± standard deviation. 
To compare sex differences in BMI group data, two way-ANOVA analysis with Bonferroni 
correction, and saturated linear regression, with robust "hc3" standard errors to address the 
differences in error variance was performed. 
Linear regression analysis was used to assess the effect of BMI on RV mass, EDV, SV, RVEF 
and RVM/VR. We assessed sex differences in the effects of BMI and other predictors using 
interaction terms in the linear regression models for each outcome. Linearity was assessed by the 
addition of a quadratic term to the regression analyses. No violations of linearity were observed. 
Normality of distribution of the standardised e rors was assessed, all standardised errors were 
normally distributed for the primary associations of interest. Values of p < 0.05 were considered 
as statistically significant.  
 
Results 
Anthropomorphic Data  
Subjects were separated into groups according to sex and World Health Organization body mass 
index (BMI) categories. Groups were well matched for age, BMI and blood pressure. In addition, 
all subjects were normotensive, normoglycaemic and normocholesterolaemic on the day of 
scanning (Table 1).  
 
Right Ventricular Function and Obesity 
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Normal and overweight weight females showed higher RVEF than their male counterparts 
(normal weight + 2.2%, overweight + 4%, p <0.01 for both analyses). Obese males and females 
had similar RVEF (Table 1). Of note, there was a positive correlation between BMI and RVEF in 
males (R 0.18, p <0.001), but not females (R 0.05, p = 0.37), a pattern that was also seen with 
total Fat Mass (males, R0.23, p=0.011, females, R0.025, p=0.75). Interestingly, there was also a 
weak positive relationship between WHR and RVEF in males and females (males; R 0.20, 
females R 0.14, both p<0.04). 
 
Sex Differences in Right Ventricular Morphology  
Right Ventricular Mass  
When comparing the regression coefficient for the effect of BMI on RV mass between males and 
females,  females showed a greater RV hypert ophic response to increasing BMI (female RV 
mass increase +1.0g per BMI point increase vs male, +0.8g per BMI point increase, p=0.02).   
To assess whether this difference was driven by the difference in regression coefficient for the 
effect of fat mass on RV mass (Table 2), a second regression model including a sex fat mass 
interaction term was performed. This showed that when fat mass was included in the model the 
sex difference in regression co efficient for the effect of BMI on RV mass became non-
significant (p=0.08). Overall this would suggest that the observed sex difference in BMI on RV 
mass may be due to a differential effect of fat mass on RV modelling.  
 
RV End-Diastolic Volume  
In contrast to females, where RV cavity size increased with increasing BMI (+1.0mls per BMI 
point increase, p<0.001, Table 1, Figure 1D), in males there was no relationship between RV 
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end-diastolic cavity size and increasing BMI (+ 0.2mls per BMI point increase, p = 0.51, Figure 
1C). As a sex difference in regression coefficient for the effect of fat mass on RV-EDV was 
observed (Table 2), this was included as an interaction term in repeat regression analysis. This 
showed that, the sex difference in effect of increasing BMI on RV-EDV remained (p<0.001).   
 
RV Mass: Volume Ratio  
Both males and females exhibited an increase in RVM/VR with increasing BMI. On comparing 
the regression coefficients, the effect of BMI on concentric hypertrophy was equal in males and 
females (males, +0.004 vs females +0.005 RVM/VR increase per BMI point increase, p=0.47, 
Figure 1 E&F). RVM/VR was also positively correlated with the secondary measures of 
adiposity (Fat mass; males R 0.47, Females R 0.61, WHR; males R 0.30, Females R 0.24, all 
p<0.001), but no sex difference in the regression coefficients was observed. A weak positive 
correlation also was seen between total cholesterol and RVM/VR was also seen in females (R 
0.15, p = 0.014). Overall, this suggests that, although cavity dilatation occurs along with elevated 
RV mass in female obesity (i.e. ecce tric hypertrophy), a degree of concentric hypertrophy, is 
still present and manifest as increased RVM/VR. 
 
RV Changes Indep ndent of LV Changes 
To investigate whether RV changes occur independently from LV changes, or reflect a response 
to a general process in obesity, all RV measures were adjusted for the appropriate LV parameter.  
When adjusted for LV-EDV, the relationship between BMI and RV-EDV did not remain 
significant in females (R-0.03, p=0.59). This suggests that the processes causing RV cavity 
dilatation are similar to those causing LV cavity dilatation. In contrast, when adjusted for LV 
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mass, RV mass remained positively correlated with BMI in women (female R 0.31, p<0.001) but 
not in men (R 0.05, p = 0.40), suggesting that the effects of obesity on RV hypertrophy in 
women are occurring in response to a mechanism independent from that affecting the LV.  
 
LV Diastolic Function and Right Ventricular Mass 
Across both sexes, LV peak diastolic filling rate was negatively correlated to both increasing 
BMI (Figure 2 A & B) and increasing LV mass (Figure 2 C & D). In addition, LV diastolic peak 
filling rate was also negatively correlated with RV mass in both men and women (Figure 2 E & 
F). Of note, the magnitude of relationship between LV peak filling rate and RV mass was similar 
in women and men (male +4.6g, females +4.5g RV mass increase per LVEDV/s decrease, both 
p<0.001).  Importantly, LV peak filling rate was also related to RV concentric remodeling (men 
+0.025, females +0.024 RV mass: volume ratio increase per LVEDV/s decrease, both analyses 
p<0.001). This would suggest that not only is LV diastolic function related to RV concentric 
remodeling, but also that the magnitude of the effect of diastolic dysfunction in causing RV 
hypertrophy is similar in men and women.  Importantly, even when adjusted for BMI and SBP, 
LV peak filling rate remained negatively correlated with RV mass (male + 2.9g, females +1.5g 
RV mass increase per LVEDV/s decrease, both p<0.001). Furthermore, as the relationship 
between RV remodeling and BMI persists after adjusting for LV filling rate (male r 0.36, 
females r 0.56, both p <0.001) this suggests that both obesity and LV diastolic function are 
related to RV hypertrophy. 
 
Comparing the Sex Specific Effects of Obesity on RV and LV Mass 
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In order to determine whether or not obesity has equal effects on RV and LV mass, the relative 
contribution of RV mass (in percentage terms) to total ventricular mass (combined RV/LV mass) 
was calculated.  As expected, total ventricular mass was moderately/strongly correlated with 
BMI (Figure 3A &B). Whereas there was no relationship between percentage contribution of RV 
mass to total mass and BMI in males, (R = 0.05, p =0.35) suggesting an equal contribution of LV 
and RV mass to increased total ventricular mass (Figure 3C), there was a positive relationship 
between percentage contribution of RV mass to total mass and BMI in females, (R = 0.30, 
p<0.001, Figure 3D). This suggests a disproportionate RV mass increase in females. Given the 
fact that the relationship between total body fat mass and RV mass is steeper in females than 
males (males +0.38g vs female +0.48g increase in RV mass (g) per Kg increase in total body fat, 
p=0.04), this would suggest that in addition to the effects of LV diastolic dysfunction, the RV in 
females is more prone to the effects of increased body fat mass. 
 
Relative Effect Size of Diastolic Function and Obesity on RV Hypertrophy 
Whereas a single BMI point increase overall was linked to a 0.8g increase in RV mass in males 
and 1.0g in females, a single BMI point increase was linked to a 0.07 decrease in LVEDV/s in 
both men and wo en (Figure 2). Assuming a linear system, a 0.07 decrease in LVEDVs would 
be expected to be associated with a +0.3g increase in female and male RV mass. Given the 
overall +0.8 and +1.0g RV mass increase per BMI point increase; this suggests that only ~30-
38% of RV hypertrophy results from LV diastolic dysfunction.  In keeping with this, even when 
adjusted for the effects of LVEDV/s the positive relationship between BMI and RV mass 
remained present, although the coefficient of regressions were reduced (male, 0.6g, females 0.9g, 
both p<0.001). 
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Discussion 
It is now well established that obesity per se is linked to increased heart failure and 
cardiovascular mortality. 
25
  Potential mechanisms for this have focused on the LV including; 
concentric hypertrophy, 
18
 diastolic dysfunction, 
16
 impaired myocardial energetics 
26
 and 
increased aortic stiffness, 
27
 all of which are present in obesity and are independent markers of 
elevated cardiovascular risk.  Although relatively under-investigated, RV hypertrophy is also 
present in obesity 
9, 10
 and is emerging as another risk factor for heart failure and cardiovascular 
death. 
4
  This study has shown that, even in the absence of traditional cardiovascular risk factors, 
not only is obesity per se linked to RV hypertrophy (providing another plausible mechanism 
behind obesity related mortality), but also that sex specific effects of obesity exist, with 
concentric RV hypertrophy in men, and mixed eccentric and concentric hypertrophy in women. 
In addition, with increasing BMI, RV hypertrophy is proportionally greater than LV hypertrophy 
in women, but equal in men. Furthermore, irrespective of sex, this study has shown that RV 
hypertrophy is correlated with LV diastolic dysfunction in both men and women.  
 
Sex Differences in Right Ventricular Hypertrophy in Response to Increasing BMI 
Although RV hypertrophy has not been widely studied in obesity, previous studies have reported 
an increase in RV mass with increasing BMI on a population basis, albeit not accounting for co-
morbidities. 
6, 9
  In addition, recent echocardiogram-based studies have highlighted sex-specific 
RV remodelling with females being more susceptible to RV hypertrophy and diastolic 
dysfunction in the metabolic syndrome.  The Multi Ethnic Study of Atherosclerosis (MESA) 
group, using CMR, have previously published that obesity is associated with RV hypertrophy 
without change in ejection fraction.
9
   However, as acknowledged by the authors, interpreting the 
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effects of obesity per se in that study is difficult given the high prevalence of hypertension, 
diabetes, hypercholesterolaemia and history of smoking and less than 2% of the MESA 
population were free of cardiovascular risk factors.  To date, our work is the only study to 
investigate the sex-specific effects of increasing BMI, in the absence of comorbidities, on RV 
geometry. We have shown that although RV hypertrophy is present in both sexes, it is 
predominantly concentric in males and mixed eccentric and concentric in females, a diff rence 
that may be driven by a sex-specific difference in the effect of fat mass on RV remodelling. 
Interestingly, this pattern is consistent with findings in the LV, where we have previously 
reported concentric remodeling in males and mixed eccentric and conc ntric remodeling in 
females. 
18
  
 
Independent Effects of Obesity on the Right Ventricle 
Although obesity is well known to have significant effects on the LV, 
18, 28
 it is not known 
whether coexisting RV hypertrophy occurs in response to the same mechanisms i.e. a 
generalized cardiac response to increased adiposity, or reflects a response to RV specific stimuli 
occurring independently of those affecting the LV. In this study we have shown that RV 
hypertrophy and cavity dilatation (female only) occur even when adjusted for the appropriate LV 
characteristics. Possible mechanisms for these effects include adipokines such as leptin which 
has been shown to be linked with rodent cardiomyocyte hypertrophy in vitro 
29
 and associated 
with RV hypertrophy in humans. 
10
 Although it seems logical that greater RV hypertrophy could 
result from obstructive sleep apnea and chronic pulmonary hypertension, the available published 
data do not necessarily support this hypothesis 
7, 8
 In fact, studies have reported that the majority 
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of obese subjects do not have enough tricuspid valve regurgitation to estimate pulmonary artery 
pressures, and those that do have generally have normal derived RV systolic pressures. 
7
  
As this study has showed that females had proportionately greater RV hypertrophy than males in 
response to increasing BMI and fat mass, independent of the effects on the left ventricle, this 
suggests either that generalized humoral factors (circulating cytokines, growth hormones, 
adipokines) such as angiotensin II, aldosterone, catecholamines, insulin and leptin have greater 
effect on RV myocardial hypertrophy in women, or that sex-specific factors, for example sex 
hormones are in some way responsible.    
 
The Effect of LV Diastolic Function on RV Mass  
Another potential mechanism for RV hypertrophy in obesity is LV diastolic dysfunction, which 
is not only present in obesity, but has been linked to RV hypertrophy in other diseases such as 
hypertension.
14
 This study has shown that even after adjustment for SBP and BMI, LV peak 
filling rate is negatively correlated with RV mass. This suggests that as LV diastolic function 
worsens, there is an accompanying increase in RV mass. RV hypertrophy in systemic 
hypertension has been attributed to LV diastolic dysfunction acting via pulmonary venous 
hypertension and increased RV end-diastolic pressure. 
12-14
 Given that obesity is linked to LV 
diastolic dysfunction 
8, 15, 16
 and that this study has shown a negative relationship between LV 
relaxation and RV mass, it is likely that a similar mechanism is responsible for at least some of 
the RV hypertrophy seen in obesity. This would then suggest that, in addition to the general 
hypertrophic effects of obesity on the left and right ventricle, there is an additional RV 
hypertrophic effect of impaired LV diastolic function.  
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Comparing the Hypertrophic Effects of Obesity in the RV and LV 
This study has shown that, in females, with increasing obesity, RV mass provides a greater 
contribution to total ventricular mass than LV mass. This pattern is not seen in males. Given the 
fact that diastolic dysfunction appears to have an equal hypertrophic effect on the RV in men and 
women, this is unlikely to be the mechanism. One potential explanation may be a differential 
susceptibility of the RV to metabolic changes.  It is now becoming clear that there are sex 
specific differences in the effects of the metabolic syndrome risk factors on RV remodeling, with 
females being more susceptible to RV hypertrophy than males in response to abdominal obesity, 
impaired fasting glucose, dyslipidemia  and systolic hypertension. 
5, 6
 In agreement with this, this 
study has showed a greater effect of obesity on RV hypertrophy in females. Given the steeper 
relationship between total body fat mass and RV mass in females, this is likely to be an effect of 
excess fat, and as a result, changes in adipokines are a possible explanation.   
 
Right Ventricular Morphology and Mortality 
It is now becoming recognized that RV hypertrophy is an independent risk factor for both heart 
failure and cardiovascular mortality. 
3
 Given the fact that obesity is now unquestionably linked to 
an increased risk of heart failure, mortality 
25
 and RV hypertrophy, it is likely that this is playing 
a role in the elevated risk associated with increased BMI. This study has shown that increasing 
BMI, in the absence of identifiable cardiovascular risk factors, and even after adjusting for age, 
blood pressure, fat mass and LV size, is associated with RV hypertrophy in both males and 
females.   
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Although there is now evidence that CMR-derived RV mass is predictive of heart failure and 
death 
4
 the effect of the pattern of RV hypertrophy (i.e. concentric or eccentric) on mortality is 
not yet known. However, given the clear differing effects of the various patterns of LV 
hypertrophy on cardiovascular mortality and morbidity 
30, 31
 it is very plausible that the same 
pattern will emerge for the RV. As this study, and others, have clearly shown sex specific-effects 
of obesity, hypertension and the metabolic syndrome on RV morphology it is likely this will turn 
out to have prognostic importance.  
 
Limitations 
The effect of elevated pulmonary pressure on RV morphology is well established but is unknown 
in this study as invasive pulmonary artery pressure reading were not performed. However, obese 
participants were excluded if they had a history of obstructive sleep apnoea. In addition, although 
the prevalence of OSA on a population basis is greater in men than women, the relatively greater 
RV hypertrophy seen in obese females would argue against this being a predominant cause.  
 
As both blood pressure and cholesterol are both related to RV remodelling and are increased in 
this study with increasing BMI, they are potential confounders to the results seen. However, as 
we have recruited subjects with normal blood pressure and cholesterol levels, observed a very 
small increase in both with increasing BMI (SBP; 5-7mmHg, Cholesterol (0.2-0.5mmol/L), and 
have performed adjusted statistical models to account for this, we are confident that the large 
changes in RV mass observed are related predominantly to obesity and not to changes in blood 
pressure or cholesterol.   
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Although RV remodeling patterns have been linked to mortality, this study is not designed or 
powered to investigate the effects of obesity related RV remodeling on cardiovascular mortality 
in this healthy population. Future, large scale population-based imaging studies such as, for 
example, UK Biobank 
32
 will be able to address this question. 
 
Conclusion 
Although the right ventricle is technically difficult to image, and has traditionally been 
overlooked, it is becoming increasingly clear that RV remodeling, and more specifically RV 
hypertrophy, is linked to increased mortality with up to a 1.9 fold increase over five years 
4
 and 
that sex differences in RV remodeling occur in multiple diseases. This study has not only shown 
that increasing BMI is associated with substantial RV hypertrophy, but also that the pattern of 
hypertrophy is different in men, where concentric remodeling occurs, to that seen in women, 
where mixed eccentric and concentric remodeling occurs. In addition, we have shown that LV 
diastolic dysfunction is linked to increased RV mass and also that RV hypertrophy in females is 
relatively greater than LV hypertrophy in obesity.  Given the increased risk of heart failure and 
mortality in obesity, it is very likely that RV remodeling is at least in part responsible for 
increased obesity related mortality and reducing it may become an important therapeutic target in 
treating obesity-related heart disease.   
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Table 1. Anthropometric and RV characteristics for the study group separated into WHO BMI categories, normal weight (BMI <25kg/m
2
), 
overweight (25 - 29.9 kg/m
2
) and obese (> 30 kg/m
2
).  
 
 
 
  
* 
 p < 0.05 Normal Weight Males versus Normal Weight Females 
‡
 p < 0.05 Obese Males versus Overweight Males  
#
 p < 0.05 Overweight Males versus Normal Weight Males  
₴ 
p < 0.05 Obese Males versus Normal Weight Males 
†
 p < 0.05 Overweight Females versus Normal Weight Females 
** 
p < 0.05 Obese Females versus Normal Weight Females  
≠
 p < 0.05 Obese Females versus Obese Males   
††
 p < 0.05 Overweight Females versus overweight Male 
 
 
  
Normal 
Weight 
Male 
(n=189) 
Normal 
Weight 
Female 
(n=210) 
Overweight 
Male 
(n=96) 
Overweight 
Female 
(n=85) 
Obese 
Male 
(n=60) 
Obese 
Female 
(n=99) 
       
Age 35  ± 12 35 ± 18 38 ± 13 42 ± 14
†
 44 ± 13
₴
 42 ± 11 
Body Mass Index (kg/m
2
) 22 ± 2 22 ± 2 27 ± 1
#
 27 ± 1 35 ± 6
‡₴
 38 ± 7 
Systolic Blood Pressure (mmHg) 120 ± 10 115 ± 10 123 ± 8 118 ± 12 125 ± 9
₴
 122 ± 12
**
 
Diastolic Blood Pressure (mmHg) 73 ± 8 71 ± 8 76 ± 7 74 ± 9 77 ± 7
₴
 76 ± 8
**
 
 
      
Right Ventricular Ejection Fraction (%) 61 ± 7
* 
63 ± 8
 
60 ± 7
††
 65 ± 6 63 ± 8 63 ± 6 
Right Ventricular End-Diastolic Volume (mL) 171 ± 30
*
 128 ± 24 175 ± 30
††
 133 ± 26 167 ± 33
≠
 144 ± 23
**
 
Right Ventricular Mass (g) 41 ± 9
*
 32 ± 8 47 ± 9
#††
 37 ± 8
† 
51 ± 11
‡₴
 48 ± 12
**
 
Right Ventricular Mass/Volume Ratio 0.24 ± 0.05
*
 0.25 ± 0.06 0.27±0.06
#
 0.28 ± 0.06
†
 0.32 ± 0.08
‡₴
 0.33 ± 0.08 
RV stroke Volume (ml) 
 
104 ± 20 81 ± 17 107 ± 20 87 ± 17 106 ± 21 92 ± 17
** 
 
Fasting Cholesterol (mmol/L) 4.4 ± 0.8 4.8 ± 0.9 4.9 ± 0.09
#
 4.8 ± 0.8
†
 4.9 ± 0.9
₴
 5.0 ± 0.8 
Fasting Glucose (mmol/L) 4.7 ± 0.5 4.7 ± 0.5 5.0 ± 0.5 4.8 ± 0.5 5.0 ± 0.6 5.0 ± 0.5
**
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Table 2. Gender Differences in Linear Regression for RV Mass, EDV and RVM/VR 
 
 
Male  Female Sex Interaction  
RV Mass (g) R
2
  p value R
2
  p value p Value  
   
   
  
 
  
 
 Body Mass Index (kg/m
2
) 0.18 0.8 <0.001 0.4 0.1 <0.001 0.009 
 Age (years) 0.08 0.06 0.14 0.01 0.02 0.61 0.998 
 Systolic Blood Pressure (mmHg) 0.04 0.22 <0.001 0.04 0.2 <0.001 0.214 
 Diastolic Blood Pressure (mmHg) 0.01 0.14 0.04 0.03 0.27 <0.001 0.06 
 Fat Mass (Kg) 0.19 0.38 <0.001 0.47 0.54 <0.001 0.047 
 Waist : Hip Ratio 0.12 34 <0.001 0.07 33.5 <0.001 0.37 
   
   
  
 
  
 
   
   
  
 
  Sex Interaction  
RV-EDV(mls) R
2
  p value R
2
  p value p Value  
   
   
  
 
  
 
 Body Mass Index (kg/m
2
) 0 0.2 0.51 0.08 0.97 <0.001 0.01 
 Age (yrs) 0.02 -0.38 0.004 0.02 -0.26 0.01 0.09 
 Systolic Blood Pressure (mmHg) 0.04 0.14 0.43 0.02 0.05 0.66 0.06 
 Diastolic Blood Pressure (mmHg) 0.03 -0.12 0.58 0.01 -0.09 0.56 0.62 
 Fat Mass (Kg) 0.002 0.04 0.87 0.16 0.56 <0.001 0.006 
 Waist : Hip Ratio 0.005 20.13 0.33 0.004 17.1 0.28 0.07 
   
   
  
 
  
 
   
   
  
 
  Sex Interaction  
RV Mass/Volume Ratio  R
2
  p value R
2
  p value p Value  
   
   
  
 
  
 
 Body Mass Index (kg/m
2
) 0.16 0.005 <0.001 0.26 0.005 <0.001 0.69 
 Age (yrs) 0.04 0.001 <0.001 0.01 0.001 0.04 0.38 
 Systolic Blood Pressure (mmHg) 0.03 0.001 0.001 0.05 0.001 <0.001 0.69 
 Diastolic Blood Pressure (mmHg) 0.02 0.001 0.01 0.05 0.002 <0.001 0.22 
 Fat Mass (Kg) 0.22 0.002 <0.001 0.37 0.003 <0.001 0.71 
 Waist : Hip Ratio 0.09 0.19 <0.001 0.06 0.19 <0.001 0.95 
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Figure Legends 
Figure 1. Sex Differences in RV Remodeling in Obesity; RV Mass (panels A&B) EDV (panels 
C&D), and RVM/VR (panels E&F). 95% confidence boundaries for regression lines are shown.  
 
Figure 2. The sex specific relationship between diastolic function and BMI (panels A&B), LV 
mass (panels C&D) and RV mass (panels E&F). 95% confidence boundaries for regression lines 
are shown. 
 
Figure 3. The sex specific differential effect of obesity on total ventricular mass (LV + RV 
Mass, g) in males (A) and Females (B), and  RV hypertrophy, presented as percentage 
contribution of RV mass to total ventricular mass  (m les C, females D).  95% confidence 
boundaries for regression lines are shown. 
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